The post-treatment phase — what to expect
Surgery is over. You're home. And now begins what many women describe as the most disorienting part of the whole process: the waiting. Your body is simultaneously trying to heal the surgical site, prevent re-adhesion, and grow new endometrium — and you have limited direct visibility into any of it.
Understanding what's normal in this phase — and what to watch for — gives you something to do with the uncertainty. It turns passive waiting into active observation.
Immediate post-op: the first few days
Some cramping and light spotting are normal in the days immediately after hysteroscopic adhesiolysis. You may notice a small amount of watery or bloody discharge. This is the uterus responding to the procedure and beginning its healing process. Mild discomfort is expected and manageable with over-the-counter pain relief.
The barrier period
Many surgeons place a physical barrier inside the uterine cavity after surgery — typically a balloon catheter or an intrauterine device (IUD) — to prevent the walls from touching and re-adhering during the critical early healing window. This is usually left in place for five to seven days, sometimes longer depending on the severity of the disease.
While it's in place, you may feel a persistent pressure or mild cramping — like a dull, heavy sensation inside the pelvis. This is expected. If the discomfort becomes severe, or is accompanied by fever, significant bleeding, or foul-smelling discharge, contact your doctor promptly.
The hormone phase
Oestrogen supplementation — typically for four to six weeks — follows removal of the barrier. Oestrogen stimulates endometrial proliferation, encouraging the lining to grow across the treated areas before they can scar again. Some women feel bloated, emotionally tender, or breast-sensitive during this period. These are expected hormonal effects. They are your body responding to the medication as intended.
Your period returning — what's meaningful
The return of your period after Asherman's treatment is one of the most emotionally loaded events in the recovery process. I want to give you a framework for reading it — not just feeling it.
"My first period post-surgery was barely there. I nearly dismissed it. But it was there — and compared to months of nothing, it felt enormous."
What the first bleed tells you
Your first post-treatment period may be light. It may be brief. It may feel anti-climactic after everything you've been through. That's okay. Any flow is a positive sign. It means the endometrium built and shed — that the fundamental hormonal-tissue cycle is operating, even if modestly.
What you're watching for over time is progression, not perfection. The trajectory from light/absent → spotting → light flow → moderate flow is what matters — and that progression may take months.
What a 'good' period looks like at steady state
A period that suggests good endometrial recovery will typically last three to five days, involve moderate flow — not flooded-pad bleeding, but consistent flow — produce few or no large clots, and involve manageable cramping rather than severe pain. You are aiming for something that feels like your pre-Asherman's baseline, not a perfect textbook period.
What to track
Use the Recovery Tracker to log this every cycle. Patterns over months tell the story far more clearly than any single cycle. When you arrive at a scan appointment or follow-up with three months of data, your clinician can see what's actually happening — not just what you remember.
Recognising signs of re-adhesion
Re-adhesion is the most significant risk in the post-treatment period, and understanding its warning signs may be the most important thing in this chapter. Caught early, re-adhesions are thin, filmy, and relatively easy to address. Left unaddressed, they become dense, fibrous, and much harder to treat.
The recurrence numbers you need to know
Up to 33% of women treated for Asherman's experience some degree of re-adhesion overall. In severe cases — women with grade III or IV disease, or those who have had multiple surgeries — that recurrence rate can reach up to 66%. These statistics are not intended to frighten you. They are intended to motivate vigilance. Re-adhesion is common enough that monitoring for it is not catastrophising — it is good medical practice.
Warning signs to watch for
- Flow becoming lighter again after initially improving. This is the most important signal. If your periods were getting better — more flow, more days, fresher colour — and then begin to regress, take it seriously.
- Cyclic pain returning without a corresponding bleed. The familiar sensation of your body cycling through the hormonal pattern, but with little or no blood emerging. This is the same mechanism as your original Asherman's symptoms — and in the post-treatment context, it warrants urgent investigation.
- Period stopping again after having returned. A period that came back and then disappears again is not just hormonal fluctuation — it deserves to be assessed.
- Pressure or cramping at expected cycle time with no blood. Particularly in the first three to six months after surgery, this pattern needs to be checked.
The follow-up hysteroscopy — what to expect
A follow-up hysteroscopy is typically scheduled four to eight weeks after your surgical procedure. This is not a routine formality — it is a critical part of your care. It gives your surgical team direct visual confirmation of how well the uterine cavity has healed.
What it shows
A good result at follow-up hysteroscopy looks like: a clear, open cavity; a visible triple-line endometrium (the three-layer appearance that indicates good endometrial development); and no obvious scar bands bridging the cavity walls. The surgeon can assess not just whether adhesions have returned, but the quality of the endometrial tissue itself — whether it looks thin and pale (suggesting inadequate response) or thick and vascular (suggesting good proliferation).
A partial result — some improvement but areas of early re-adhesion — is common and not cause for despair. It typically means a further procedure, probably a simpler one than the original, to address the areas that haven't fully healed.
How to prepare
Track your cycles leading up to the appointment. Arrive knowing your last three periods: dates, duration, volume, any pain. If your surgeon finds adhesions at the follow-up, it helps enormously to have a discussion beforehand about what they will do in that event. Ideally, they will have the ability to treat same-session — to address any new adhesions during the same procedure rather than scheduling a separate return. Ask about this in advance.
Ultrasound monitoring — reading your lining
Transvaginal ultrasound in the follicular phase — around days 10 to 12 of your cycle — allows your clinician to measure endometrial thickness and assess its pattern. This is one of your most important ongoing monitoring tools.
What the numbers mean
| Thickness | Interpretation | What it means for you |
|---|---|---|
| <5mm | Very thin | Poor prognosis for implantation at this thickness; discuss next steps with your clinician |
| 5–7mm | Thin to borderline | Suboptimal but may be workable in some contexts; watch for improvement over cycles |
| ≥8mm | Target threshold | Generally considered adequate for receptivity; most fertility specialists use 8mm as the minimum for embryo transfer |
| ≥10mm | Good | Associated with better implantation outcomes; aim for this over time if possible |
Pattern matters as much as thickness
The triple-line pattern — in which the endometrium shows three distinct echogenic layers on ultrasound — is a positive sign of good endometrial receptivity. It indicates that the endometrium is proliferating properly under oestrogen stimulation. An endometrium that is even 8mm but homogeneous (without the triple-line) is considered less receptive than one of the same thickness with a clear trilaminar pattern.
Watch the trend over multiple cycles. A single scan tells you where you are today. Three scans over three months tells you whether things are moving in the right direction — and that trajectory is what your care team should be tracking alongside you.
Bring your Recovery Tracker data to every scan appointment. Being able to say "my last three periods were X, and my previous scan showed Y" means your clinician spends less time reconstructing history and more time interpreting what's happening now.
Pregnancy considerations after treatment
If pregnancy is your goal — and for many women reading this guide, it is — then this section is the one you've been building toward. I want to give you an honest picture: genuinely encouraging, and genuinely realistic.
When to try
Most specialists advise waiting at least two to three months after treatment before attempting to conceive. This allows the endometrium time to recover and stabilise, and gives you at least one or two monitored cycles to assess how the lining is responding before placing that additional demand on it.
Elevated pregnancy risks — what you need to know
Pregnancies after Asherman's treatment carry elevated risks compared to the general population. This does not mean that a healthy pregnancy is unlikely — many women with a history of Asherman's go on to have uncomplicated pregnancies and healthy babies. But it means that if you conceive, you should be under the care of a high-risk obstetric team who are aware of your history from the outset.
- Placenta accreta/previa — the placenta may implant abnormally in areas of prior scarring; this requires specialist management and delivery planning
- Intrauterine growth restriction (IUGR) — a compromised endometrium may be less able to support adequate placental function throughout pregnancy
- Preterm delivery — rates are elevated in women with a history of significant intrauterine adhesions
- Recurrent miscarriage — if adhesions have not fully resolved or if the endometrium is inadequately repaired, implantation loss risk remains elevated
The risks listed above are not inevitable. They are possibilities that need to be watched for and managed — with the right team, from the right time. Many women with a significant Asherman's history have delivered healthy babies. The risks are real; they are also manageable with appropriate care.
Longer-term monitoring
Even when things look good — follow-up hysteroscopy clear, endometrial thickness improving, periods returning toward normal — ongoing monitoring is worthwhile for 12 to 24 months after treatment.
The endometrium can continue to improve over time. It can also re-adhere — sometimes silently, without dramatic symptom changes. A period that gradually becomes slightly lighter over a few cycles may not trigger an alarm in the moment, but looking back over six months of tracker data it becomes clear. That's why regular data collection matters even in the \"good\" period.
Annual check-ups with your gynaecologist are sensible — more frequent if you are actively trying to conceive or if your treatment history involved severe disease. The goal is not anxiety-driven over-monitoring. It is remaining connected to your care team with enough data to detect early changes when they still represent an easy fix.
Staying in that relationship — with your body, with your tracker, with your medical team — is not a sign that you haven't moved past this. It is a sign that you understand how Asherman's works, and that you are managing it intelligently rather than hoping it stays fixed on its own.
Your monitoring toolkit
The Recovery Tracker is designed specifically to support the kind of ongoing, cycle-by-cycle observation this chapter has been describing. Here is a practical framework for how to use it:
Your data tells the story more clearly than memory. Clinicians working with incomplete information have to guess; clinicians working with three months of cycle logs can see exactly what's happening and when the pattern changed. Use the Recovery Tracker.
This chapter has been about active, informed observation — not fearful vigilance. The difference matters. You are not watching for disasters. You are collecting evidence about how your body is healing, so that you and your medical team can respond quickly when something needs addressing, and feel genuinely reassured when the data shows that things are moving in the right direction.
Chapter 7 moves forward into life after active treatment — what recovery looks like emotionally and practically when the cycle of surgery and waiting is behind you, and you are beginning to build something new.